While metformin remains common initial therapy, GLP-1 receptor agonists may be appropriate first-line therapy in selected patients, particularly those with cardiovascular disease, heart failure, or chronic kidney disease
Symptoms of B12 deficiency
In the UK, winter is a common turning point
So a BPC-157 course does not end because it stopped working
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
A head-to-head meta-analysis pooling 16 trials reached the same conclusionno meaningful difference in erectile outcomes or overall adverse-event ratesthough tadalafil scored better on some psychological satisfaction measures, likely thanks to its longer coverage window (systematic review and meta-analysis)